Literature DB >> 29264718

Resistance to trypanocidal drugs in cattle populations of Zambezia Province, Mozambique.

Fernando Chanisso Mulandane1, José Fafetine2, Jan Van Den Abbeele3, Peter-Henning Clausen4, Antje Hoppenheit4, Giuliano Cecchi5, Marinda Oosthuizen6, Vincent Delespaux7, Luis Neves2,6.   

Abstract

African animal trypanosomosis is a debilitating tsetse-transmitted parasitic disease of sub-Saharan Africa. Therapeutic and prophylactic drugs were introduced more than 50 years ago, and drug resistance is increasingly reported. In a cross-sectional study, 467 cattle were microscopically screened for trypanosomes. Samples were collected in May-July 2014 from five villages (Botao, Mungama, Zalala-Electrosul, Zalala-Madal, and Namitangurine) in Nicoadala district, Zambezia province. To evaluate treatment efficacy, trypanosome-positive animals in each village were randomly assigned to two groups, one treated with 0.5 mg/kg b.w. isometamidium (Inomidium®), the second with 3.5 mg/kg b.w. diminazene (Inomazene®). Cattle were microscopically monitored at days 0, 14, and 28 post-treatment. At day 28, trypanocides were swapped to investigate single or multiple resistance. Microscopically negative samples from the monitoring days were tested using 18S-PCR-RFLP. 22.9% (107/467) was found positive on day 0. On day 14, nine animals in Botao and seven in Mungama were positive. On day 28, in Botao, four animals from the diminazene group and four from the isometamidium group were positive. In Mungama, four animals from the diminazene group were positive on day 28. On day 42, six animals (9%) in Botao and two (9.5%) in Mungama remained positive after drug swap. No relapses occurred in Namitangurine. The 18S-PCR-RFLP consistently detected more positive than microscopy: indeed, positives reached 12, 13, and 8 in Botao and 9, 7, and 4 in Mungama, at days 14, 28, and 42, respectively. Single- and multi-drug resistance in Nicoadala district, Zambezia province, is thus here confirmed. This should be considered when choosing control options.

Entities:  

Keywords:  African animal trypanosomosis; Block treatment; Chemo-resistance; PCR-RFLP; Trypanocides

Mesh:

Substances:

Year:  2017        PMID: 29264718     DOI: 10.1007/s00436-017-5718-1

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  46 in total

1.  Transport of isometamidium (Samorin) by drug-resistant and drug-sensitive Trypanosoma congolense.

Authors:  I A Sutherland; A Mounsey; P H Holmes
Journal:  Parasitology       Date:  1992-06       Impact factor: 3.234

2.  PCR-RFLP using Ssu-rDNA amplification as an easy method for species-specific diagnosis of Trypanosoma species in cattle.

Authors:  D Geysen; V Delespaux; S Geerts
Journal:  Vet Parasitol       Date:  2003-01-02       Impact factor: 2.738

3.  Prevalence of Trypanosoma sp. in cattle from Tanzania estimated by conventional PCR and loop-mediated isothermal amplification (LAMP).

Authors:  Dusit Laohasinnarong; Oriel M M Thekisoe; Imna Malele; Boniface Namangala; Akihiro Ishii; Yasuyuki Goto; Shin-Ichiro Kawazu; Chihiro Sugimoto; Noboru Inoue
Journal:  Parasitol Res       Date:  2011-07-08       Impact factor: 2.289

Review 4.  Some general aspects of the distribution and epidemiology of bovine trypanosomosis in southern Africa.

Authors:  P Van den Bossche
Journal:  Int J Parasitol       Date:  2001-05-01       Impact factor: 3.981

5.  Five-fold increase in Trypanosoma congolense isolates resistant to diminazene aceturate over a seven-year period in Eastern Zambia.

Authors:  Vincent Delespaux; Hunduma Dinka; Justin Masumu; Peter Van den Bossche; Stanny Geerts
Journal:  Drug Resist Updat       Date:  2008-11-06       Impact factor: 18.500

6.  Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei.

Authors:  Enock Matovu; Mhairi L Stewart; Federico Geiser; Reto Brun; Pascal Mäser; Lynsey J M Wallace; Richard J Burchmore; John C K Enyaru; Michael P Barrett; Ronald Kaminsky; Thomas Seebeck; Harry P de Koning
Journal:  Eukaryot Cell       Date:  2003-10

Review 7.  The trypanosomiases.

Authors:  Michael P Barrett; Richard J S Burchmore; August Stich; Julio O Lazzari; Alberto Carlos Frasch; Juan José Cazzulo; Sanjeev Krishna
Journal:  Lancet       Date:  2003-11-01       Impact factor: 79.321

8.  Multiple Trypanosoma infections are common amongst Glossina species in the new farming areas of Rufiji district, Tanzania.

Authors:  Imna I Malele; Henry B Magwisha; Hamisi S Nyingilili; Kamilius A Mamiro; Elipidius J Rukambile; Joyce W Daffa; Eugene A Lyaruu; Lupakisyo A Kapange; Gideon K Kasilagila; Nicodemus K Lwitiko; Halifa M Msami; Elikira N Kimbita
Journal:  Parasit Vectors       Date:  2011-11-17       Impact factor: 3.876

9.  Monitoring the elimination of human African trypanosomiasis: Update to 2014.

Authors:  José R Franco; Giuliano Cecchi; Gerardo Priotto; Massimo Paone; Abdoulaye Diarra; Lise Grout; Raffaele C Mattioli; Daniel Argaw
Journal:  PLoS Negl Trop Dis       Date:  2017-05-22

Review 10.  Human African trypanosomiasis.

Authors:  Philippe Büscher; Giuliano Cecchi; Vincent Jamonneau; Gerardo Priotto
Journal:  Lancet       Date:  2017-06-30       Impact factor: 79.321

View more
  2 in total

1.  Evaluation of the relative roles of the Tabanidae and Glossinidae in the transmission of trypanosomosis in drug resistance hotspots in Mozambique.

Authors:  Fernando C Mulandane; Louwtjie P Snyman; Denise R A Brito; Jeremy Bouyer; José Fafetine; Jan Van Den Abbeele; Marinda Oosthuizen; Vincent Delespaux; Luis Neves
Journal:  Parasit Vectors       Date:  2020-04-29       Impact factor: 3.876

2.  The potential economic benefits of controlling trypanosomiasis using waterbuck repellent blend in sub-Saharan Africa.

Authors:  Zewdu Abro; Menale Kassie; Beatrice Muriithi; Michael Okal; Daniel Masiga; Gift Wanda; Ouedraogo Gisèle; Abah Samuel; Etienne Nguertoum; Rock Aimé Nina; Philémon Mansinsa; Yahaya Adam; Mamadou Camara; Pamela Olet; Diarra Boucader; Susana Jamal; Abdoul Razak Issa Garba; Joseph Joachim Ajakaiye; Jean Felix Kinani; Mohamed Adam Hassan; Hezron Nonga; Joyce Daffa; Ambrose Gidudu; Kalinga Chilongo
Journal:  PLoS One       Date:  2021-07-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.